medigraphic.com
ISSN 2992-8559 (Electronic)
ISSN 1405-0625 (Print)

2022, Number 3

<< Back Next >>

Cir Plast 2022; 32 (3)

Paracetamol vs selective blocker Na(v) 1.8 in the Duran-Houser protocol and the flexor tendon repair

Rendón-Medina MA, Hanson-Viana E, Sashida-Méndez H, Mendoza-Vélez MÁ, Hernández-Ordoñez R, Vázquez-Morales HL, Pacheco-López RC

Language: Spanish
References: 20
Page: 117-121
PDF size: 203.18 Kb.


ABSTRACT

Recent research suggests that ambroxol is related to the blocking of sodium influx during action potential in nociceptive neurons. This work aims to at comparing pain management, without analgesics, with paracetamol or with ambroxol, in patients with tenorrhaphy. Patients were assigned to three groups. Group A received no analgesic treatment, group B was treated with ambroxol, and group C was treated with paracetamol. Pain assessment was done using the Duran-Houser protocol at in each joint. We collected 31 cases in one month. Pain was present in group A at 3-4 on the visual analogue scale, 2-4 in group B and 2-4 in group C. No significant difference was found between the 3 groups in any of the weeks evaluated. We conclude that our findings showed a lack of association and that ambroxol does not increase pain tolerance, compared to those using paracetamol, or to patients receiving no analgesic. In addition, we found no difference in functional outcomes after rehabilitation, so no further analysis was necessary.


REFERENCES

  1. Osnaya-Moreno H, Romero-Espinosa JF, Mondragón-Chimal MA, Ochoa-González G et al. Estudio epidemiológico de las lesiones traumáticas de mano en un Centro Médico de Toluca, Estado de México. Cir Cir 2014; 82 (5): 511-516.

  2. López L, Estrada R. Repercusión ocupacional de las amputaciones traumáticas en dedos de la mano por accidente de trabajo. Med Segur Trab 2009; 55 (217): 41-48.

  3. Schoffl V, Heid A, Kupper T. Tendon injuries of the hand. World J Orthop 2012; 3 (6): 62-69.

  4. Talsma E, de Haart M, Beelen A, Nollet F. The effect of mobilization on repaired extensor tendon injuries of the hand: a systematic review. Arch Phys Med Rehabil 2008; 89 (12): 2366-2372. doi: 10.1016/j.apmr.2008.06.019.

  5. Chesney A, Chauhan A, Kattan A, Farrokhyar F et al. Systematic review of flexor tendon rehabilitation protocols in zone II of the hand. Plast Reconstr Surg 2011; 127 (4): 1583-1592. doi: 10.1097/PRS.0b013e318208d28e.

  6. Athwal GS, Wolfe SW. Treatment of acute flexor tendon injury: Zones III-V. Hand Clin 2005; 21 (2): 181-186. doi: 10.1016/j.hcl.2004.11.007.

  7. Tang JB, Amadio PC, Boyer MI et al. Current practice of primary flexor tendon repair. A global view. Hand Clin 2013; 29 (2): 179-189. doi: 10.1016/j.hcl.2013.02.003.

  8. Groth GN. Current practice patterns of flexor tendon rehabilitation. J Hand Ther 2005; 18 (2): 169-174. doi: 10.1197/j.jht.2005.01.010.

  9. Tang JB. Recent evolutions in flexor tendon repairs and rehabilitation. J Hand Surg Eur Vol 2018; 43 (5): 469-473. doi: 10.1177/1753193418773008.

  10. Verdan C, Potenza AD. Tendon surgery of the hand. Vol 66. Philadelphia: Elsevier Inc.; 1980. doi: 10.1097/00006534-198008000-00029.

  11. Harris SB, Harris D, Foster AJ et al. The etiology of acute rupture of flexor tendon repairs in zones 1 and 2 of the fingers during early mobilization. J Hand Surg Am 1999; 24 (3): 275-280. doi: 10.1054/jhsb.1998.0212.

  12. Seiler III JG. Flexor tendon injury. In: Wolfe SW, Hotchkiss RN, Pederson WC, Kozin SH, Cohen MS, eds. Green's operative hand surgery. 7th ed. Philadelphia: Elsevier; 2018. pp. 183-230.

  13. Eggli S, Dietsche A, Eggli S, Vogelin E. Tenolisis after combined digital injuries in zone II. Ann Plast Surg 2005; 55 (3): 266-271. doi: 10.1097/01.sap.0000174357.03839.2a.

  14. Baskies MA, Tuckman DV, Paksima N. Management of flexor tendon injuries following surgical repair. Bull NYU Hosp Jt Dis 2008; 66 (1): 35-40.

  15. Suzuki S, Gerner P, Colvin AC, Binshtok AM. C-fiber-selective peripheral nerve blockade. Open Pain J 2009; 2 (1): 24-29. doi: 10.2174/1876386300902010024.

  16. Gaida W, Klinder K, Arndt K, Weiser T. Ambroxol, a Nav1.8-preferring Na+ channel blocker, effectively suppresses pain symptoms in animal models of chronic, neuropathic, and inflammatory pain. Neuropharmacology 2005; 49 (8): 1220-1227. doi: 10.1016/j.neuropharm.2005.08.004.

  17. Kern KU, Schwickert-Nieswandt M, Maihofner C, Gaul C. Topical ambroxol 20% for the treatment of classical trigeminal neuralgia - A new option? initial clinical case observations. Headache 2019; 59 (3): 418-429. doi: 10.1111/head.13475.

  18. Kern KU, Weiser T. Topical ambroxol for the treatment of neuropathic pain. An initial clinical observation. Schmerz 2015; 29 Suppl 3 (Suppl 3): S89-S96. doi: 10.1007/s00482-015-0060-y.

  19. Cantor AB. Sample size calculations for Cohen's kappa. Psychol Methods 1996; 1 (2): 150-153. doi: 10.1037/1082-989X.1.2.150.

  20. Strickland JW, Glogovac SV. Digital function following flexor tendon repair in Zone II: A comparison of immobilization and controlled passive motion techniques. J Hand Surg Am 1980; 5 (6): 537-543. doi: 10.1016/S0363-5023(80)80101-8.




2020     |     www.medigraphic.com